The Conversation (0)
Cardiome Pharma announced the expansion for Brinavess into new territories, South Africa and Pakistan.
Cardiome Pharma (NASDAQ:CRME; TSX:COM) announced the expansion for Brinavess into new territories, South Africa and Pakistan.
As quoted in the press release:
Following the recent receipt of authorization from South Africa’s Department of Health, Brinavess was launched in South Africa by Cardiome’s partner Aspen Medical, preparing for the first sale of the product on the African continent.
Cardiome is eligible to receive payments from Aspen Medical based on pre-specified annual commercial goals. Aspen Medical, who also markets Aggrastat in South Africa, is a wholly-owned subsidiary of Aspen Pharmacare (a division of the Aspen Group), the largest pharmaceutical company in Africa. In addition to this commercial launch, a Cardiome affiliate, Correvio International Sàrl, entered into an exclusive license and distribution agreement with ATCO Laboratories Limited that will advance Brinavess toward commercialization in Pakistan.
Click here to read the full press release.
Source: www.newswire.ca
